Topical Treatments for Hirsutism
Eflornithine hydrochloride cream 13.9% (Vaniqa) is the only FDA-approved topical pharmacologic treatment for unwanted facial hair in women with hirsutism, and should be used either alone for mild cases or in combination with laser therapy for enhanced results. 1
Primary Topical Pharmacologic Treatment
Eflornithine Hydrochloride Cream 13.9%
Eflornithine is an irreversible inhibitor of ornithine decarboxylase, the enzyme that catalyzes the rate-limiting step for follicular polyamine synthesis necessary for hair growth. 1
The cream does not remove existing hair but reduces the rate of new hair growth. 1
Noticeable results require 6-8 weeks of consistent application, and hair returns to pretreatment levels approximately 8 weeks after discontinuation. 1
Systemic absorption is extremely low, making it safe for long-term use. 1
Side effects are minimal, limited to itching and dry skin with clinical use; skin irritation only occurs with experimental overuse conditions. 1
Evidence for Eflornithine Efficacy
Open-label and randomized trials demonstrate that eflornithine reduces both the growth and appearance of facial hair while improving quality of life. 1
Two RCTs comparing laser treatment of the upper lip combined with eflornithine versus placebo showed significantly greater hair reduction with eflornithine, particularly in the early treatment phase (up to week 22 in one trial). 1
In one trial, 42% of subjects reported better hair reduction with eflornithine compared to placebo, though 58% perceived no difference, highlighting variable individual response. 1
Combination Therapy Strategy
Eflornithine should be combined with photoepilation (laser or IPL) for optimal results, as this combination provides both immediate hair removal and ongoing growth suppression. 1
The combination approach addresses the limitation that eflornithine alone does not remove existing hair, requiring concurrent mechanical or energy-based removal methods. 1
Randomized trials confirm enhanced efficacy when eflornithine is used as an adjunct to laser therapy compared to laser alone. 1
Alternative Topical Approaches (Non-Pharmacologic)
Temporary Cosmetic Methods
Bleaching with hydrogen peroxide and sulfates can mask unwanted facial hair but does not remove it; side effects include irritation, pruritus, and possible skin discoloration. 1
Chemical depilatories containing thioglycolates dissolve hair by disrupting disulfide bonds but have an unpleasant odor and can cause irritant dermatitis. 1
Topical Anesthetics for Procedural Pain
- Topical lidocaine-prilocaine anesthetic creams may reduce pain associated with electrolysis procedures. 1
Important Clinical Considerations
Treatment Duration and Expectations
All hirsutism therapies require a minimum of 6 months before assessing efficacy due to the length of the hair growth cycle. 2, 3
Lifelong treatment is often necessary for sustained benefit, as hair regrowth occurs when treatment is discontinued. 3
Limitations of Topical Therapy Alone
Topical eflornithine as monotherapy is most appropriate for mild hirsutism; moderate to severe cases require systemic antiandrogens (spironolactone, finasteride) or combined oral contraceptives. 3, 4
Even with photoepilation destroying hair follicles, vellus hair follicles can continually convert to terminal pigmented hairs when androgen excess persists, explaining why many women experience regrowth. 1
Emerging Research
- Experimental formulations such as spironolactone-loaded hyaluronic acid enriched cerosomes show promise for topical delivery of antiandrogens, potentially minimizing systemic side effects while providing local therapeutic benefit. 5